Showing results (141-150 of 432) with videos related to
Sort By:
Pageof 44
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|June 8, 2013
Psychopathology and psychosocial adjustment in patients with HIV-associated lipodystrophyAnna Barata, Jorge Malouf, Mar Gutierrez, et al.The American Journal of Medicine|January 29, 2002
Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal diseasePere Domingo, Eduardo Muñiz-Diaz, Maria A Baraldès, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 30, 2013
Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophyJosé M Gallego-Escuredo, Joan Villarroya, Pere Domingo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP studyJosep Mallolas, Daniel Podzamczer, Ana Milinkovic, et al.Antiviral Therapy|November 30, 2005
Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trialAna Barrios, Eugenia Negredo, Pere Domingo, et al.Antiviral Therapy|February 22, 2007
HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophyMarta Giralt, Pere Domingo, Jordi P Guallar, et al.The Journal of Antimicrobial Chemotherapy|August 18, 2010
Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patientsAdrian Curran, Mar Gutirerrez, Elisabet Deig, et al.Current HIV Research|July 20, 2010
Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patientsEcheverria Patricia, Pere Domingo, Mar Gutierrez, et al.Journal of Leukocyte Biology|July 18, 2008
Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acidsFernando Zapata-Gonzalez, Felix Rueda, Jordi Petriz, et al.HIV Clinical Trials|January 14, 2017
Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudyMaria Saumoy, Juan M Tiraboschi, Jordi Ordoñez-Llanos, et al.Pageof 44